Late Stage Investors & VC Firms in Brazil
65 firms in this list, with a median first check of $385K. 33 of them lead rounds. Generated from verified public data and updated continuously.
Khosla Ventures
Menlo ParkPre-Seed–Late Stage$5K – $50M
44 people
Headline
San FranciscoPre-Seed–Late Stage$1M – $50M
86 people
Point72 Ventures
New YorkSeed–Late Stage$1M – $75M
11 people
Commerce Ventures
San FranciscoPre-Seed–Late Stage$1M – $5M
18 people
Advent International
BostonSeries A–Late Stage$1.1B
36 people
Vivo Capital
Palo AltoSeed–Late Stage$10M – $50M
11 people
General Atlantic
StamfordSeries B–Late Stage$10M – $1B
9 people
Maniv Mobility
Tel-AvivPre-Seed–Late Stage$1M – $5M
8 people
Graphene Ventures
Palo AltoGrowth–Late Stage$500K – $2M
12 people
Thrive Capital
Fort WashingtonSeed–Late Stage$500K – $25M
4 people
Ethos VC
San FranciscoPre-Seed–Late Stage$250K – $3M
5 people
Liquid Ventures
San FranciscoPre-Seed–Late Stage$250K – $5M
12 people
VEF
Seed–Late Stage$5K – $5M
7 people
Atomico
LondonSeed–Late Stage
11 people
b2venture
BerlinPre-Seed–Late Stage$270K – $5.4M
11 people
Impact Fund Denmark
Copenhagen KSeed–Late Stage$2.2M – $70.2M
11 people
Invest Tech
São PauloPre-Seed–Late Stage
DGF
São PauloSeed–Late Stage
6 people
PruVen Capital Partners
Palo AltoSeed–Late Stage$100K – $10M
6 people
Dragoneer Investment Group
San FranciscoSeries A–Late Stage$100K – $5M
Fuel Venture Capital
CovinaSeed–Late Stage
6 people
Acon Investments
Washington D.C.Seed–Late Stage
CSC Upshot
Palo AltoPre-Seed–Late Stage$100K – $1.5M
3 people
ICONIQ Capital
Seed–Late Stage$5M – $100M
Related lists
Seed Investors & VC Firms (7051)Series A Investors & VC Firms (4959)Investors & VC Firms in United States (2654)Series B Investors & VC Firms (2615)Pre-Seed Investors & VC Firms (2349)Late Stage Investors & VC Firms (2244)Seed Investors & VC Firms in United States (2211)Series A Investors & VC Firms in United States (2107)Growth Investors & VC Firms (1963)Series C Investors & VC Firms (1701)
Data sourced from public filings and firms' own websites — see our methodology.




